OTLK as of Nov 2 · 11:11 ET
OTLKNasdaqBiological Products, (No Diagnostic Substances)

Outlook Therapeutics, Inc. · Brief

Next report

56 days

Dec 28 · before openest.Q4 FY26

Expected move

Inputs

Implied vs realized

1 reportHistory
—≥ implied
Q3 FY26±23.6%▼−14.90%×0.63
quarterimplied−25%0+25%realized×
Q3 FY26±23.6%▼−14.90%×0.63
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Dec 28 report · est.

Bull2 of 3

67managers reporting a position in the latest quarterly filings13F · Jun 30 '26
1 of 17largest reporting managers cutting their stake in the latest quarter13F · Jun 30 '26

Bear1

10managers whose positions together make up four fifths of the reported value13F · Jun 30 '26
AI captions · Sep 16 '26once per report · top 2 per case

Linked exposure

OTLK report session

No linked exposure.

Latest changes

30 daysAll changes

No changes.

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.